Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia

Med Clin (Barc). 2022 Aug 26;159(4):e25-e26. doi: 10.1016/j.medcli.2021.12.001. Epub 2022 Jan 1.

[Article in English, Spanish]

Authors

Fatma Yildirim¹, Irem Karaman², Meltem Şimşek³

Affiliations

¹ University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Clinic of Chest Diseases, COVID Intensive Care Unit, Ankara, Turkey. Electronic address: ftagassi@hotmail.com.
² School of Medicine, Bahcesehir University, Turkey.
³ University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Department of Internal Medicine, COVID Intensive Care Unit, Ankara, Turkey.

No abstract available

Publication types

Letter
Comment

MeSH terms

Ascorbic Acid / therapeutic use
COVID-19*
Humans
Pneumonia*
Prognosis
SARS-CoV-2

Substances

Ascorbic Acid